Controversies in antibiotic choices for odontogenic infections

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 101, Issue 6, 2006, Pages 697-698

  Stefanopoulos, Panagiotis K ^a   Kolokotronis, Alexandros E ^b  

^a Periodontal Department   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; HETEROCYCLIC COMPOUND; MOXIFLOXACIN; QUINOLINE DERIVATIVE;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; DRUG EFFECT; HUMAN; LETTER; MICROBIOLOGY; SPAIN; STREPTOCOCCUS INFECTION; TOOTH INFECTION;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; FOCAL INFECTION, DENTAL; HUMANS; QUINOLINES; SPAIN; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 33646846464     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2005.10.065     Document Type: Letter

References (10)

1. Chow A.W. Infections of the oral cavity, neck, and head. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. (2005), Elsevier, Churchill Livingstone, Philadelphia, PA 787-802
2. Gilbert D.N., Moellering Jr. R.C., Eliopoulos G.M., and Sande M.A. The Sanford Guide to Antimicrobial Therapy 2005. 35th ed. (2005), Antimicrobial Therapy, Inc, Hyde Park, VT 30, 33
3. Sobottka I., Cachovan G., Stürenburg E., et al. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother 46 (2002) 4019-4021
4. Schmitz F.-J., Verhoef J., and Fluit A.C. Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. J Antimicrob Chemother 43 (1999) 783-792
5. Smith A., Jackson M.S., and Kennedy H. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents. Scand J Infect Dis 36 (2004) 259-263
6. Gershon A.S., de Azavedo J.C.S., McGeer A., et al. Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000. Antimicrob Agents Chemother 46 (2002) 1553-1556
7. Gordon K.A., Beach M.L., Biedenbach D.J., Jones R.N., Rhomberg P.R., and Mutnick A.H. Antimicrobial susceptibility patterns of β-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 43 (2002) 157-162
8. Seppälä H., Haanperä M., Al-Juhaish M., Järvinen H., Jalava J., and Huovinen P. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Chemother 52 (2003) 636-644
9. Al-Belasy F.A., and Hairam A.R. The efficacy of azithromycin in the treatment of acute infraorbital space infections. J Oral Maxillofac Surg 61 (2003) 310-316
10. Addy L.D., and Martin M.V. Azithromycin and dentistry-a useful agent. Br Dent J 197 (2004) 141-143